SRTA latest filing

Recent Insider Trading Activity Strata Critical Medical, Inc. (SRTA) Recent Insider Trading Activity From Our SEC Form 4 Tracker

Ticker Filing Date Company Insider Title Transaction Shares Price Total Value Position Size Change SEC Filing
SRTA 2026-08-13 Strata Critical Medical, Inc. Love Reginald Director Sell 5,091 $5.75 $29,273.25 3.36% View Filing
SRTA 2026-06-10 Strata Critical Medical, Inc. Tomkiel Melissa M. Co-CEO and General Counsel Sell 29,730 $5.87 $174,515.10 1.57% View Filing
SRTA 2026-06-10 Strata Critical Medical, Inc. Heyburn William A. Co-CEO and CFO Sell 31,671 $5.87 $185,908.77 2.04% View Filing
SRTA 2026-06-10 Strata Critical Medical, Inc. Wunsch Scott M CEO, Logistics Sell 5,550 $5.87 $32,578.50 0.89% View Filing
SRTA 2026-06-10 Strata Critical Medical, Inc. Cohen Amir Chief Accounting Officer Sell 4,655 $5.87 $27,324.85 3.18% View Filing

Real-time employee trading alerts from SEC Form 4 filings.

Pricing

Free Trial

10 trading days
$0

Explore every Premium feature before you pay.

  • Full platform access
  • 10 trading days
  • No credit card required
Start your free trial

Standard Monthly

Scheduled
$19.99 / month

Scheduled alerts with complete trade context.

  • Email and Telegram delivery
  • Alert intervals from every sixty minutes to once daily
  • Filter by insider title, buy/sell, transaction value, DRIP, ESPP, 10b5-1, and tax liability coverage transfers
  • Highlighted cluster transactions and direct SEC filing links
Choose Standard Monthly

Premium Monthly

Recommended
$29.99 / month

Fastest alerts with ticker-level control.

  • Everything in Standard
  • Instant delivery detection-to-outbound time averages 0.84 seconds
  • Alert intervals starting from one minute
  • Filter alerts by ticker
Choose Premium Monthly
Student discount: Customers who sign up with a verified .edu email address receive 50% off for the first four years. On monthly plans, the first month is the full 75% off.
Alerts are based on public SEC filings and are provided for informational purposes only; they do not constitute financial advice.